AMPHIRION DEEP PTA BALLOON CATHETER
Report
- Report Number
- 9612164-2021-03910
- Event Type
- Injury
- Date Received
- October 12, 2021
- Date of Event
- June 24, 2013
- Report Date
- January 31, 2022
- Manufacturer
- MEDTRONIC MEXICO
- Product Code
- DQY
- PMA / PMN Number
- K052791
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IT
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
AGE OR DATE OF BIRTH: AVERAGE AGE. SEX: MAJORITY GENDER. EVENT DATE: DATE OF ARTICLE PUBLICATION DRUG-ELUTING BALLOON IN PERIPHERAL INTERVENTION FOR BELOW THE KNEE ANGIOPLASTY EVALUATION (DEBATE-BTK) A RANDOMIZED TRIAL IN DIABETIC PATIENTS WITH CRITICAL LIMB ISCHEMIA CIRCULATION (2013) 128:615¿621 10.1161/CIRCULATIONAHA.113.001811. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
A JOURNAL ARTICLE WAS SUBMITTED WHICH AIMED TO INVESTIGATE THE EFFICACY OF A PACLITAXEL DRUG-ELUTING BALLOONS VERSUS CONVENTIONAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) FOR THE REDUCTION OF RESTENOSIS IN DIABETIC PATIENTS WITH CRITICAL LIMB ISCHEMIA UNDERGOING ENDOVASCULAR INTERVENTION OF BELOW-THE-KNEE ARTERIES. RESULTS REPORTED FROM THE DRUG-ELUTING BALLOON IN PERIPHERAL INTERVENTION FOR BELOW THE KNEE ANGIOPLASTY EVALUATION (DEBATE-BTK). 132 PATIENTS WITH 158 LESIONS IN 143 LIMBS WERE INCLUDED IN THE STUDY. THE ARTICLE REPORTED DEBATE STUDY WAS CARRIED OUT FOR ALL CONSECUTIVE DIABETIC PATIENTS WITH CLI UNDERGOING ANGIOGRAPHY OF AT LEAST ONE BELOW THE KNEE VESSEL, WERE SCREENED FOR ENROLMENT. MEDTRONIC'S INPACT AMPHIRION DEB AND AMPHIRION DEEP PTA WERE USED IN THE STUDY. THE STUDY WAS DIVIDED INTO TWO GROUPS, DEB VS PTA. THE LESIONS WERE RANDOMLY ASSIGNED TO ONE OF THE TWO STUDY ARMS. NO MAJOR ADVERSE EVENT OCCURRED IN THE HOSPITAL. IT WAS REPORTED THAT EIGHT PATIENTS DIED DURING FOLLOW UP; CAUSES OF DEATH INCLUDED SUDDEN DEATH, RESPIRATORY FAILURE, STROKE, HEART FAILURE AND SEPSIS. FIVE PATIENTS HAD WORSENING OF PRE-EXISTING RENAL FAILURE, TWO PATIENTS HAD MAJOR STROKE, TWO PATIENTS HAD CONGESTIVE HEART FAILURE. AMPUTATION, RESTENOSIS, AND OCCLUSION WERE REPORTED FOR OTHER PATIENTS. THERE IS NO ESTABLISHED OR SUSPECTED CAUSAL RELATIONSHIP BETWEEN THE DEVICE(S) AND THE DEATH EVENTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1513742 | AMPHIRION DEEP PTA BALLOON CATHETER | CATHETER, PERCUTANEOUS | DQY | MEDTRONIC MEXICO |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 75 YR | Male | Required Intervention |